Clinical Trials Browser

Interventional × Neoplasms × MRX-2843 × Clear all

NCT03510104 2026-01-08

Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Pathologic Processes